I did notice that many of the facts did seem dated. The trials were wrong in many instances and it left out quite a few trials as well. However I did enjoy reading it. I would like to see what Summerton thinks now. The father of Antisense would be good read.
Bionerd-This is dlbiggreenbball.So...The the $64,000. question is....? Have we solved the delivery problem that they have talked about in the article.I guess there isn'nt a delivery problem with Resten-Ng in cardiovascular restenosis because it is scrape loaded. But how about our other platforms? You're saying that this article is from 3 years ago? I think Summerton started Gene Tools in Feb or March of 1999. Feedback?? Bionerd? Redplate? Thanks!